{
  "pmcid": "5052188",
  "sha256": "7dce7db87717ce458e6deea7d3d447fa83324635baa0172e05af934f7b699610",
  "timestamp_utc": "2025-11-09T22:44:58.650910+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.709943422913721,
    "reading_ease": 35.41028052805285,
    "word_count": 202
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Collagenase Clostridium Histolyticum Injection for Adhesive Capsulitis"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this randomised controlled trial, 60 patients with adhesive capsulitis were recruited"
      },
      "Participants": {
        "score": 2,
        "evidence": "60 patients with adhesive capsulitis were recruited based on restricted active ROM of at least 60° in the affected shoulder"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive a single injection of 0.5 mL placebo or 0.145, 0.29, or 0.58 mg CCH"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy of collagenase clostridium histolyticum (CCH) injections compared to physical therapy"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was active forward flexion improvement at 30 days"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "In this randomised controlled trial, 60 patients with adhesive capsulitis were recruited"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "CCH at 0.58 mg/1 mL and 0.58 mg/2 mL showed greater improvement in active forward flexion compared to exercise alone (mean difference: 26° and 31°, p = 0.03 and p = 0.01, respectively)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not disclosed"
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}